ADMA - ADMA BIOLOGICS, INC.

QQQ $ 446.38 $ 0.61 (0.14 %)

DIA $ 395.05 $ 6.75 (1.74 %)

SPY $ 528.63 $ 0.00 (0 %)

TLT $ 96.30 $ 0.15 (0.16 %)

GLD $ 224.00 $ 3.46 (1.57 %)

Previous Close

$ 12.19

Open

Bid

$ 12.17 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 3.06 - $ 14.03

Volume

4,084,844

Average Volume

Market Cap

2.95B

Beta (5Y Monthly)

$ 0.66

PE Ratio (TTM)

$ 84.85

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	02-28-2024	12-31-2023	10-K
4	11-08-2023	09-30-2023	10-Q
5	08-09-2023	06-30-2023	10-Q
6	05-10-2023	03-31-2023	10-Q
7	03-23-2023	12-31-2022	10-K
8	11-09-2022	09-30-2022	10-Q
9	08-10-2022	06-30-2022	10-Q
10	05-11-2022	03-31-2022	10-Q
11	03-24-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-11-2021	06-30-2021	10-Q
14	05-12-2021	03-31-2021	10-Q
15	03-25-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-05-2020	06-30-2020	10-Q
18	05-06-2020	03-31-2020	10-Q
19	03-13-2020	12-31-2019	10-K
20	11-06-2019	09-30-2019	10-Q
21	08-08-2019	06-30-2019	10-Q
22	05-08-2019	03-31-2019	10-Q
23	03-13-2019	12-31-2018	10-K
24	11-09-2018	09-30-2018	10-Q
25	08-10-2018	06-30-2018	10-Q
26	05-14-2018	03-31-2018	10-Q
27	03-29-2018	12-31-2017	10-K
28	11-03-2017	09-30-2017	10-Q
29	08-11-2017	06-30-2017	10-Q
30	05-12-2017	03-31-2017	10-Q
31	02-24-2017	12-31-2016	10-K
32	11-10-2016	09-30-2016	10-Q
33	08-12-2016	06-30-2016	10-Q
34	05-13-2016	03-31-2016	10-Q
35	03-23-2016	12-31-2015	10-K
36	11-10-2015	09-30-2015	10-Q
37	08-11-2015	06-30-2015	10-Q
38	05-12-2015	03-31-2015	10-Q
39	03-09-2015	12-31-2014	10-K
40	11-10-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

ADMA Biologics Raises FY24 Total Revenue G...
08/08/2024 21:12:54

Upwardly Revised 2024-2025 Financial Guidance: FY 2024 and 2025 total revenue is now expected to be more than $400 millio...

ADMA Biologics Q2 2024 GAAP EPS $0.13 Beat...
08/08/2024 20:37:36

ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.07 ...

jim-cramer-recommends-not-selling-vertiv-says-buy-this-social-media-stock-hand-over-fist

Jim Cramer Recommends Not Selling Vertiv, ...
07/23/2024 13:16:10

Mad Money's Jim Cramer recommends holding on to Vertiv Holdings, which is set to report its Q2 results before the opening b...

leslies-issues-preliminary-financial-results-joins-beyond-meat-dominos-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session

Leslie's Issues Preliminary Financial Resu...
07/18/2024 12:22:49

how-is-the-market-feeling-about-adma-biologics

How Is The Market Feeling About ADMA Biolo...
07/11/2024 16:30:24

Expert Ratings For ADMA Biologics
07/09/2024 17:00:21

Cantor Fitzgerald Maintains Overweight on ...
07/09/2024 13:23:08

Cantor Fitzgerald analyst Kristen Kluska maintains ADMA Biologics (NASDAQ:ADMA) with a Overweight and raises the price targe...

Peeling Back The Layers: Exploring ADMA Bi...
06/20/2024 13:01:06

Mizuho Maintains Buy on ADMA Biologics, Ra...
06/20/2024 12:14:58

Mizuho analyst Anthony Petrone maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price target from $12 to $14.

Raymond James Maintains Strong Buy on ADMA...
05/10/2024 16:57:38

Raymond James analyst Elliot Wilbur maintains ADMA Biologics (NASDAQ:ADMA) with a Strong Buy and raises the price target fro...

why-diodes-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Why Diodes Shares Are Trading Lower By Aro...
05/10/2024 16:44:44

Cantor Fitzgerald Maintains Overweight on ...
05/10/2024 15:02:56

Cantor Fitzgerald analyst Kristen Kluska maintains ADMA Biologics (NASDAQ:ADMA) with a Overweight and raises the price targe...

genpact-posts-upbeat-earnings-joins-groupon-natera-funko-cargurus-and-other-big-stocks-moving-higher-on-friday

Genpact Posts Upbeat Earnings, Joins Group...
05/10/2024 14:48:27

adma-biologics-analysts-increase-their-forecasts-after-upbeat-results

ADMA Biologics Analysts Increase Their For...
05/10/2024 12:32:39

HC Wainwright & Co. Maintains Buy on ADMA ...
05/10/2024 12:08:12

HC Wainwright & Co. analyst Raghuram Selvaraju maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price ta...

Mizuho Maintains Buy on ADMA Biologics, Ra...
05/10/2024 11:58:25

Mizuho analyst Anthony Petrone maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price target from $10 to $12.

ADMA Biologics Sees FY25 Revenue More Than...
05/09/2024 21:15:50

ADMA Biologics Sees FY24 Revenue More Than...
05/09/2024 21:15:40

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
05/09/2024 20:31:07

ADMA Biologics Q1 2024 GAAP EPS $0.08 Beat...
05/09/2024 20:28:08

ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.05 ...